Explore
Premium
Sign Up
Log In
CRT 2017 : Japan FDA - Using Real-World Evidence to Support Marketing, Post-Marketing Safety Measures and Regulatory Decisions
Conference
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$10.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Overview
Japan FDA - Using Real-World Evidence to Support Marketing, Post-Marketing Safety Measures and Regulatory Decisions
Featuring
Mitchell Krucoff
Hiroyoshi Yokoi
Pablo Morales
Jenny Andersen
Akihide Konishi
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$10.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Moment Components
Methods to Gather and Analyze RWE – US Academia - Mitchell Krucoff
Current Methodology and Future Horizons – Japanese Academia - Hiroyoshi Yokoi
Regulatory Perspectives on RWE – US Regulatory View - Pablo Morales
Issues and Current Experience Using RWE to Support Regulatory Applications – US Industry - Jenny Andersen
Using Post-Marketing Surveillance for Safety Measure – Japanese Regulatory View - Akihide Konishi
Target Audience
Learning Objectives
Related Moments
CRT 2016 Best Abstracts Fellows Certification Course - Fellows Certification Course
Conference
Fellows Certification Course at CRT 2016
Selecting the Appropriate Ablation Strategy: the Role of Endocardial and/or Epicardial Access
Journal
Article on Selecting the Appropriate Ablation Strategy: the Role of Endocardial and/or Epicardial Access
CRT 2017 : PRIMER FOR ENDOVASCULAR INTERVENTIONS - Femoropopliteal Arterial Disease
Conference
Loading Simple Education